Gilla Kaplan

Q: What Schools Are Affiliated With Gilla Kaplan

Gilla Kaplan is affiliated with the following schools: University of Cape Town, Rutgers University, University of Southern California, Rockefeller University, University of Medicine and Dentistry of New Jersey, University of Padua, Kyoto University

Gilla Kaplan's AcademicInfluence.com Rankings

Gilla Kaplan

Philosophy

#6455

World Rank

#9491

Historical Rank

Logic

#3617

World Rank

#4806

Historical Rank

philosophy Degrees

Gilla Kaplan

Biology

#8783

World Rank

#11914

Historical Rank

Immunology

#508

World Rank

#525

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Gilla Kaplan's Degrees

PhD Immunology University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Gilla Kaplan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gilla Kaplan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes (1991) (1215)
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation (1993) (1038)
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. (1999) (770)
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response (2004) (710)
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β (2001) (600)
Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens (2008) (594)
Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset (1998) (580)
Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin (1994) (572)
Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro (1979) (502)
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism (2010) (400)
Metformin as adjunct antituberculosis therapy (2014) (396)
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. (2010) (384)
The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice (2003) (363)
Human dendritic cells. Enrichment and characterization from peripheral blood (1982) (360)
Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity (2003) (355)
Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load (2011) (322)
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. (1999) (320)
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. (1986) (315)
Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production (1999) (308)
The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro (2007) (305)
Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. (2005) (292)
Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing (1992) (278)
The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin (1987) (274)
Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients (2003) (273)
Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy (2002) (268)
Thalidomide Treatment Reduces Tumor Necrosis Factor α Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis (1995) (266)
Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. (2007) (262)
Mycobacterium tuberculosis Catalase and Peroxidase Activities and Resistance to Oxidative Killing in Human Monocytes In Vitro (1999) (259)
Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. (2005) (248)
Differential Monocyte Activation Underlies Strain-Specific Mycobacterium tuberculosis Pathogenesis (2004) (236)
In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen (1982) (234)
Differences in the Mode of Phagocytosis with Fc and C3 Receptors in Macrophages (1977) (230)
Thalidomide inhibits the replication of human immunodeficiency virus type 1. (1993) (227)
Macrophages in tuberculosis: friend or foe (2013) (222)
Arachidonic acid metabolism by human monocytes. Studies with platelet- depleted cultures (1983) (221)
Staphylococcus aureus RN6390 Replicates and Induces Apoptosis in a Pulmonary Epithelial Cell Line (2000) (211)
Immunopathologic Effects of Tumor Necrosis Factor Alpha in Murine Mycobacterial Infection Are Dose Dependent (2000) (208)
Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles1 (2008) (178)
The Cutaneous Infiltrates of Leprosy (1982) (176)
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. (2004) (176)
A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. (2008) (174)
Keratinocyte growth regulation by the products of immune cells (1988) (172)
Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system (1999) (162)
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients (1992) (161)
The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. (1996) (160)
Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice (1997) (159)
Immunity to intracellular bacteria. (1996) (159)
TNF-α Controls Intracellular Mycobacterial Growth by Both Inducible Nitric Oxide Synthase-Dependent and Inducible Nitric Oxide Synthase-Independent Pathways1 (2001) (158)
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity. (1996) (158)
Survival of Mycobacterium avium andMycobacterium tuberculosis in Acidified Vacuoles of Murine Macrophages (1999) (156)
Salmonid macrophages: separation, in vitro culture and characterization (1981) (155)
Selection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity (1996) (155)
The Role of MmpL8 in Sulfatide Biogenesis and Virulence of Mycobacterium tuberculosis* (2004) (153)
Arginine Usage in Mycobacteria-Infected Macrophages Depends on Autocrine-Paracrine Cytokine Signaling (2010) (145)
A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. (1998) (145)
Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction (2008) (142)
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. (2008) (137)
The Phenolic Glycolipid of Mycobacterium tuberculosis Differentially Modulates the Early Host Cytokine Response but Does Not in Itself Confer Hypervirulence (2008) (137)
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. (1998) (136)
The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. (2006) (134)
Macrophage activation in vivo and in vitro. (1977) (129)
Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. (1985) (127)
Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. (2003) (126)
The distinctive features of influenza virus infection of dendritic cells. (1998) (125)
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. (1999) (123)
Antibody Profiles Characteristic of Mycobacterium tuberculosis Infection State (2005) (122)
Induction of ER Stress in Macrophages of Tuberculosis Granulomas (2010) (121)
GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. (1994) (118)
Adjunctive Thalidomide Therapy for Childhood Tuberculous Meningitis: Results of a Randomized Study (2004) (116)
Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use (1996) (115)
Rainbow trout macrophages in vitro: morphology and phagocytic activity. (1982) (112)
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis (2013) (110)
Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns. (2013) (109)
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. (1987) (108)
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2 (1983) (107)
Role of activated macrophages in antibody-dependent lysis of tumor cells (1980) (104)
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization (1989) (103)
Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. (1993) (103)
Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro. (2003) (103)
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2 (1989) (100)
Mycobacterial Antigens Exacerbate Disease Manifestations in Mycobacterium tuberculosis-Infected Mice (2002) (100)
Thalidomide for the treatment of AIDS-associated wasting. (2000) (97)
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. (1982) (95)
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response (2011) (93)
Transmission of tuberculosis in a South African community with a high prevalence of HIV infection. (2015) (93)
Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. (1997) (92)
Distribution and turnover of Langerhans cells during delayed immune responses in human skin (1987) (91)
Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states. (2010) (91)
Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction. (1988) (90)
HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. (2009) (90)
H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes (1996) (89)
The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy (1991) (89)
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients. (1999) (89)
The wide utility of rabbits as models of human diseases (2018) (87)
The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. (1997) (87)
Association of Human TLR1 and TLR6 Deficiency with Altered Immune Responses to BCG Vaccination in South African Infants (2011) (87)
Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis (2012) (85)
rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. (1997) (85)
Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. (2004) (85)
Plasma Cytokines, Cytokine Antagonists, and Disease Progression in African Women Infected with HIV-1 (1996) (84)
Thalidomide and a Thalidomide Analogue Inhibit Endothelial Cell Proliferation in vitro (1999) (84)
Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8+ T Cell Response1 (2006) (83)
Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection (1993) (82)
Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy. (2000) (81)
An analysis of in vitro T cell responsiveness in lepromatous leprosy (1985) (80)
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. (2011) (80)
Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid – Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs (2011) (80)
Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro. (1997) (78)
Innate Immune Response to Mycobacterium tuberculosis Beijing and Other Genotypes (2010) (77)
In vitro differentiation of human monocytes. Monocytes cultured on glass are cytotoxic to tumor cells but monocytes cultured on collagen are not (1983) (77)
Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy (2009) (77)
Evaluation of the Mtb72F Polyprotein Vaccine in a Rabbit Model of Tuberculous Meningitis (2006) (77)
The selective binding and transmigration of monocytes through the junctional complexes of human endothelium (1988) (76)
Ribonucleotide Reduction in Mycobacterium tuberculosis: Function and Expression of Genes Encoding Class Ib and Class II Ribonucleotide Reductases (2003) (75)
Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals (1995) (75)
Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement. (2002) (73)
On the mechanism of internalization of opsonized particles by rat Kupffer cells in vitro. (1976) (72)
Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits (2013) (70)
Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages (2012) (70)
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. (1987) (69)
Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study (2015) (69)
Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice (2011) (69)
Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. (2010) (68)
The generation of antigen-specific, major histocompatibility complex- restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2 (1989) (67)
Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. (1999) (65)
Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. (2010) (64)
Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. (1996) (64)
BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. (2007) (63)
Advances in immunotherapy for tuberculosis treatment. (2009) (63)
Characterization of the Divergent Wound-Healing Responses Occurring in the Pathergy Reaction and Normal Healthy Volunteers1 (2006) (62)
Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation. (2005) (62)
Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. (2000) (62)
A metabolic biosignature of early response to anti-tuberculosis treatment (2014) (62)
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions (2016) (61)
The role of cytokines in the immune response to tuberculosis. (1996) (61)
Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. (2009) (61)
Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis (2002) (61)
Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Mycobacterium smegmatis-Induced Cytokine Production by Human Macrophages In Vitro (2001) (59)
In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolates. (2005) (58)
Mycobacterium leprae Inhibits Dendritic Cell Activation and Maturation1 (2007) (58)
Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro (1997) (58)
Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes (1993) (57)
Adjunctive Thalidomide Therapy of Childhood Tuberculous Meningitis: Possible Anti-Inflammatory Role (2000) (57)
Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice (1987) (56)
Influence of delayed immune reactions on human epidermal keratinocytes. (1986) (56)
Role of the DinB Homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis (2010) (56)
Immune stimulation in scleroderma patients treated with thalidomide. (2000) (55)
Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae. (1989) (55)
Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route (1997) (55)
Cytokine regulation of disease progression in leprosy and tuberculosis. (1994) (55)
Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis (2012) (54)
Thalidomide protects mice against LPS-induced shock. (1997) (52)
Adverse reactions to thalidomide in patients infected with human immunodeficiency virus. (1997) (52)
Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry. (2015) (52)
Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. (1993) (51)
HIV-M. Leprae Interaction: Can HAART Modify the Course of Leprosy? (2008) (50)
Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity. (2000) (50)
Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. (2006) (50)
Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model (2016) (49)
Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. (1990) (49)
‘ZS-MDR-TB' versus ‘ZR-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility (2012) (47)
Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease (2013) (46)
Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study (2016) (46)
Recombinant cytokines for controlling mycobacterial infections. (1995) (46)
Function and Regulation of Class I Ribonucleotide Reductase-Encoding Genes in Mycobacteria (2008) (46)
Mycobacterium leprae Actively Modulates the Cytokine Response in Naïve Human Monocytes (2009) (46)
The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients (1988) (41)
Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity. (2012) (40)
Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth (2009) (38)
Rational Immunotherapy with Interleukin 2 (1992) (38)
Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis. (2017) (38)
Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection (2013) (37)
Administration of recombinant interleukin-2 reduces the local parasite load of patients with disseminated cutaneous leishmaniasis. (1990) (37)
Recent advances in cytokine therapy in leprosy. (1993) (37)
Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis (2013) (37)
Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. (1986) (36)
Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL. (1998) (36)
Detection and treatment of subclinical tuberculosis. (2012) (36)
Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood–brain barrier in an animal model of acute bacterial meningitis (2000) (35)
Suppressive effect of leukemia virus-infected lymphoid cells on in vitro immunization of normal splenocytes. (1974) (35)
Experimental Tuberculosis in the Wistar Rat: A Model for Protective Immunity and Control of Infection (2011) (35)
The cutaneous infiltrates of leprosy. A transmission electron microscopy study (1983) (35)
Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use. (1996) (34)
Induction of Granulysin and Perforin Cytolytic Mediator Expression in 10-Week-Old Infants Vaccinated with BCG at Birth (2010) (34)
Nonadherent cultures of human monocytes kill Mycobacterium smegmatis, but adherent cultures do not (1996) (33)
Regulation of Acquired Immunity by γδ T‐Cell/Dendritic‐Cell Interactions (2005) (33)
Exposure of Cord Blood to Mycobacterium bovis BCG Induces an Innate Response but Not a T-Cell Cytokine Response (2008) (32)
Localization of receptors and early events of phagocytosis in the macrophage. (1975) (31)
Thalidomide in toxic epidermal necrolysis (1999) (31)
Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. (2009) (30)
A Subset of Circulating Blood Mycobacteria-Specific CD4 T Cells Can Predict the Time to Mycobacterium tuberculosis Sputum Culture Conversion (2014) (29)
Leprosy and cell-mediated immunity. (1991) (29)
A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis (2018) (29)
Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis. (1995) (28)
The immunobiology of leprosy. (1986) (28)
Specific T cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis, Following BCG Vaccination of Newborns (2010) (28)
The Morphology of Echinoid Phagocytes and Mouse Peritoneal Macrophages During Phagocytosis in Vitro (1977) (27)
Modulation of Hyperoxia-induced TNF-α Expression in the Newborn Rat Lung by Thalidomide and Dexamethasone (2000) (26)
Properties of a murine monocytic tumor cell line J-774 in vitro. I. Morphology and endocytosis. (1978) (26)
Coinfection of fibroblasts with Coxiella burnetti and Toxoplasma gondii: to each their own. (2000) (26)
Strain-specific mycobacterial lipids and the stimulation of protective immunity to tuberculosis. (2005) (25)
Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin. (1988) (24)
Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis (2016) (24)
Difference in the Effect of Immobilized Ligands on the Fc and C3 Receptors of Mouse Peritoneal Macrophages in Vitro (1978) (24)
Regulation of acquired immunity by gamma delta T-cell/dendritic-cell interactions. (2005) (23)
Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis. (2014) (23)
Epidemiologic consequences of microvariation in Mycobacterium tuberculosis. (2012) (22)
Immunohistological characterization of spinal TB granulomas from HIV-negative and -positive patients. (2013) (22)
Reversal of leukemia virus-induced immunosuppression in vitro by peritoneal macrophages. (1975) (22)
T- and B-cell-independent activation of syngeneic macrophages by murine sarcoma cells. (1980) (22)
Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosis. (1998) (21)
Mycobacterium leprae alters classical activation of human monocytes in vitro (2016) (21)
Intradermal Recombinant Interleukin 2 Enhances Peripheral Blood T‐Cell Responses to Mitogen and Antigens in Patients with Lepromatous Leprosy (1990) (21)
Differential Gene Expression in Response to Adjunctive Recombinant Human Interleukin-2 Immunotherapy in Multidrug-Resistant Tuberculosis Patients (1998) (21)
Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa (2016) (21)
Mycobacterium leprae-induced interferon-gamma production by household contacts of leprosy patients: association with the development of active disease. (1991) (21)
In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro. (1991) (20)
Regulation of cell-mediated immunity in lepromatous leprosy. (1986) (20)
Modulation of the cytokine response in human monocytes by mycobacterium leprae phenolic glycolipid-1. (2012) (20)
Endocytosis by Macrophages (1980) (20)
Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267. (2002) (19)
Gemfibrozil Inhibits Legionella pneumophila and Mycobacterium tuberculosis Enoyl Coenzyme A Reductases and Blocks Intracellular Growth of These Bacteria in Macrophages (2009) (19)
Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals. (1990) (19)
SHORT ANALYTICAL REVIEW Thalidomide as an Anti-TNF-a Inhibitor: Implications for Clinical Use (1996) (18)
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols. (2021) (18)
Macrophages phagocytose thymic lymphocytes with productively rearranged T cell receptor alpha and beta genes (1988) (17)
How Mycobacterium leprae infects peripheral nerves. (1999) (17)
Detection of Mycobacterium tuberculosis in latently infected lungs by immunohistochemistry and confocal microscopy. (2014) (17)
bis-Molybdopterin Guanine Dinucleotide Is Required for Persistence of Mycobacterium tuberculosis in Guinea Pigs (2014) (16)
Aerosol Infection of Mice with Mycobacteria Using a Nose-Only Exposure Device (1997) (16)
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis (2017) (15)
Effect of rhuIFN-gamma treatment in multibacillary leprosy patients. (1996) (15)
Quantitative and Functional Differences between Peripheral Blood Myeloid Dendritic Cells from Patients with Pleural and Parenchymal Lung Tuberculosis (2006) (15)
Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions. (2000) (14)
Dose-Dependent Immune Response to Mycobacterium bovis BCG Vaccination in Neonates (2006) (13)
Dendritic Cells and Macrophages — Current Knowledge of Their Distinctive Properties and Functions (1980) (13)
The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected children. (2001) (13)
Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2. (1989) (13)
BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model (2011) (13)
Experimental Animal Models of Tuberculosis (2017) (12)
Rational vaccine development--a new trend in tuberculosis control. (2005) (12)
TNFα regulation of HIV1: biology and therapy (1994) (12)
Properties of a murine monocytic tumor cell line J-774 in vitro. II. Enzyme activities. (1978) (12)
Hansen's disease, cell-mediated immunity, and recombinant lymphokines. (1991) (11)
Effect of treatment on the cellular composition of cutaneous lesions in leprosy patients. (1984) (11)
Effect of cutaneous cell-mediated immune response to rIFN gamma on Mycobacterium leprae viability in the lesions of lepromatous leprosy. (1992) (11)
Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology (2021) (11)
Plasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals. (2013) (11)
Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin. (2002) (11)
A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings (2016) (11)
Cellular immunity in lepromatous and tuberculoid leprosy. (1985) (11)
A multidrug-resistant, acr1-deficient clinical isolate of Mycobacterium tuberculosis is unimpaired for replication in macrophages. (2006) (10)
Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model (2020) (10)
Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community. (2014) (9)
In Vitro Cytotoxicity of Mouse Macrophages Activated by Coculture with Syngeneic Sarcoma Cells (1982) (9)
Aerosol Exposure System for Rabbits: Application to M. Tuberculosis Infection (2006) (9)
Pulmonary Tuberculosis in the Rabbit (2016) (9)
Inoculum size and traits of the infecting clinical strain define the protection level against Mycobacterium tuberculosis infection in a rabbit model (2019) (8)
Frequency of Circulating CD4+Ki67+HLA-DR− T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion (2018) (8)
Tuberculosis control in crisis-causes and solutions. (2020) (8)
Genetic Variation in TLR Genes in Ugandan and South African Populations and Comparison with HapMap Data (2012) (8)
Heterogeneity in surface glycoproteins of mouse peritoneal macrophage populations. (1981) (7)
Aggregated Mycobacterium tuberculosis Enhances the Inflammatory Response (2021) (7)
Pulmonary Tuberculosis in the Rat (2010) (7)
The emerging role of thalidomide therapy in HIV-infected patients (1997) (6)
Effects of Intradermal Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Langerhans Cell Recruitment and Keratinocyte Growth (1993) (6)
Molecular mechanism of nerve infection in leprosy. (1999) (6)
HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load. (2011) (6)
DENDRITIC CELLS, AN IMPORTANT NEW CELL TYPE IN MHC-LINKED FUNCTIONS (1980) (5)
The efficacy of a cell-mediated reaction in the disposal of M. leprae in human skin. (1988) (5)
Rabbit model of mycobacterial diseases. (2015) (5)
Leprosy a model for cell mediated immunity: the effects and consequences of recombinant lymphokine immunotherapy (1992) (5)
Thalidomide in Multiple Myeloma—From the Clinic to the Laboratory (2002) (5)
The Role of Receptors in Endocytosis (1981) (4)
Induction of Macrophage Microbicidal Activity (1980) (4)
Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis (2002) (4)
Author Correction: The wide utility of rabbits as models of human diseases (2018) (4)
Dendritic Cells in Host Immunity to Mycobacterium tuberculosis (2005) (4)
Structural Modifications of Thalidomide Produce Analogues with Enhanced Tumor Necrosis Factor Inhibitory Activity. (1996) (4)
Hansen's disease as a research model. (1984) (3)
Thalidomide Exerts Its Inhibitory Action on Tumor Necrosis Factor oe by Enhancing m R N A Degradation (2003) (3)
TNF alpha regulation of HIV1: biology and therapy. (1994) (3)
Tuberculosis research comes of age (1998) (3)
BCG Vaccination of Infants Confers Mycobacterium tuberculosis Strain-Specific Immune Responses by Leukocytes. (2020) (2)
Tuberculosis: integrating host and pathogen biology. A summary of the 2005 Keystone Symposia. (2006) (2)
Amino‐Substituted Thalidomide Analogues: Potent Inhibitors of TNF‐α Production. (1999) (2)
Tumour-activated macrophages as effector cells in a tumour neutralization assay in vivo. (1983) (2)
Human α-1-acid Glycoprotein Inhibits TNF Production in the CNS of Rabbits with Meningitis: A Report of Preliminary Observations (2004) (2)
The role of rIL-2 in the modulation of cellular immunity in resistance to infection. (1991) (2)
Cell mediated immunity in lepromatous and tuberculoid leprosy (1985) (2)
Placenta Derived Stem Cells (PDAC) Suppress the Allo-MLR and the EBV Regression Assay. (2006) (2)
Inhibitors of TNF-Thalidomide Analogues That Are Potent Activation by Two Distinct Classes of Differential Cytokine Modulation and T Cell (1999) (2)
Thalidomide Selectively Inhibits Tumor Necrosis Factor ac Production by Stimulated (1991) (1)
Macrophages in tuberculosis: friend or foe (2013) (1)
Gemfibrozil Inhibits Legionella pneumophila and Mycobacterium tuberculosis (2009) (1)
TB day summit in upstate New York: Key issues to address (2009) (1)
HowMycobacterium lepraeinfects peripheral nerves (1999) (1)
The role of rIL-2 in the modulation of cellular immunity in resistance to infection. (1991) (1)
Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits (2013) (1)
Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages (2012) (1)
CTL differentiation and function (PP-108) (2010) (0)
Complex Cytokine and Phenotypic Profiles Human Newborns Induces T Cells with Bacillus Calmette-Guérin Vaccination of (2008) (0)
Cellular Immune Response toMycobacterium lepraeInfection in Human Immunodeficiency Virus-Infected Individuals (1995) (0)
Dramatically Impaired BCG‐specific Immune Response in HIV+ Infants (2008) (0)
Endocytic trafficking and the mycobacterial vacuole - General discussion I (1998) (0)
Thalidomide Exerts Its Inhibitory Action on Tumor Necrosis Factor oe by Enhancing mRNA Degradation By Andre L. Moreira,* Elizabeth P. Sampaio,*S Antonina Zmuidzinas,* (1993) (0)
A novel role for C–C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis (2018) (0)
Tuberculosis research comes of age. Keystone Symposium on Tuberculosis: Molecular Mechanisms and Immunologic Aspects. (1998) (0)
Cell-mediated immunity to mycobacteria: the effect of cytolysis on parasite viability (1992) (0)
Association of Toll-like Receptor polymorphisms with variation in BCG-induced immunity (2009) (0)
Cytokine and phenotypic profiles of specific T cells induced by newborn BCG vaccination (47.1) (2007) (0)
Immunity to mycobacterial infection (PP-061) (2010) (0)
Gaudernack, G. Preparation and characterization of a monoclonal antibody against human monocytes (2003) (0)
The Rabbit Model for Assessing Host-Directed Therapies for Tuberculosis (2020) (0)
THALIDOMIDE IN TOXIC EPIDERMAL NECROLYSIS. AUTHOR'S REPLY (1999) (0)
The resuscitation-promoting factors of are required for virulence and resuscitation from dormancy bu (2011) (0)
Placenta Derived Adherent Cells (PDACs) Suppress Tumor Cells of Diverse Origin. (2006) (0)
Isolates Vivo and In Vitro , But Is Not More Virulent Induces a More Vigorous Host Response In CDC 1551 Mycobacterium tuberculosis (1999) (0)
LoadHumans Is Associated with Mycobacterial -Specific T Cell Responses in tuberculosis Mycobacterium Functional Capacity of (2011) (0)
TB - The Next Frontier (2014) (0)
Association of Toll-like Receptor polymorphisms with variation in BCG-induced immunity (133.33) (2009) (0)
Reply to Crawford (2006) (0)
Mycobacterium leprae alters classical activation of human monocytes in vitro (2016) (0)
The role of cytokines in protection and immunopathology in tuberculosis (1995) (0)
VolunteersPathergy Reaction and Normal Healthy Wound-Healing Responses Occurring in the Characterization of the Divergent (2006) (0)
The influence of M. Leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen (1989) (0)
Immunity to intracellular bacteria: editorial overview (1996) (0)
The US-Japan Cooperative Medical Science Program Tuberculosis and Leprosy Panel's 36th Annual Research Conference, New Orleans, Louisiana, USA, 15-17 July 2001. Abstracts. (2002) (0)
The Role of Resuscitation Promoting Factors in the Virulence of Mycobacterium tuberculosis (2007) (0)
Tuberculosis Research at the Millennium: A report from the Fourth International Conference on the Pathogenesis of Mycobacterial Infection, Stockholm, Sweden (2000) (0)
Immune Suppression by Placenta Derived Adherent Cells (PDAC) Correlate with Monocyte Chemoattractant Protein-1 and IL-2 Secretion. (2006) (0)
Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895)) (2002) (0)
Su.84. Cytokine Profile of Specific T-Cells Induced By Newborn Bcg Vaccination (2006) (0)
BCG vaccination of infants confers Mycobacterium tuberculosis strain-specific immune responses to leucocytes (2020) (0)
CD1d/NKT cells (WS-006) Chairpersons: Ken-ichiro Seino, Dale Godfrey (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gilla Kaplan?

Gilla Kaplan is affiliated with the following schools:

Gilla Kaplan's Academic­Influence.com Rankings

Gilla Kaplan's Degrees

Why Is Gilla Kaplan Influential?

Gilla Kaplan's Published Works

Published Works

What Schools Are Affiliated With Gilla Kaplan?

Gilla Kaplan's AcademicInfluence.com Rankings